Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

A20/20 Biolabs, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

20/20 Biolabs, Inc.

$0.47Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $730.57K. Net result −$1.51M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $730.57K. Running result $730.57K. One Test: $695.95K. Bio Check: $34.62K.
  • Cost of revenue: −$425.84K. Running result $304.73K.
  • Gross profit: $304.73K. Running result $304.73K.
  • Sales, general and administrative: −$1.29M. Running result −$986.59K.
  • Research and development: −$257.63K. Running result −$1.24M.
  • Operating income: −$1.24M. Running result −$1.24M.
  • Other expense: −$262.12K. Running result −$1.51M.
  • Pre-tax loss: −$1.51M. Running result −$1.51M.
  • Income tax benefit: $0. Running result −$1.51M.
  • Net loss: −$1.51M. Running result −$1.51M.